Immunotherapy and Liver Transplantation The Future or the Failure?

被引：4

作者：

Tabrizian, Parissa ^{[1
]}

Yu, Allen ^{[1
]}

Debnath, Neha ^{[1
]}

Myers, Bryan ^{[1
]}

Marron, Thomas ^{[1
]}

机构：

[1] Icahn Sch Med Mt Sinai, Recanati Miller Transplantat Inst, Liver Transplant & Hepatobiliary Surg, One Gustave L Levy, New York, NY 10029 USA

来源：

SURGICAL CLINICS OF NORTH AMERICA | 2024年 / 104卷 / 01期

关键词：

Liver transplantation; Hepatocellular carcinoma; Immunotherapy; Rejection; Outcomes; RESECTABLE HEPATOCELLULAR-CARCINOMA; ATEZOLIZUMAB PLUS BEVACIZUMAB; NEOADJUVANT THERAPY; OPEN-LABEL; PHASE-III; TRIAL; RISK; PEMBROLIZUMAB; NIVOLUMAB; ADJUVANT;

D O I：

10.1016/j.suc.2023.07.009

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

center dot The increasing demand for liver transplantation (LT) for hepatocellular carcinoma (HCC) has led to the continued efforts to expand LT indications.center dot Immunotherapy has revolutionized the treatment of advanced HCC over the past few years.center dot HCC and other solid tumors exploit evolutionary conserved inhibitory immune checkpoints to evade antitumor immune response by upregulating cognate ligands or receptors capable of inhibiting antitumor immunity.

引用

页码：163 / 182

页数：20

共 50 条

[31] The Future of Liver Transplantation
Varo Perez, E.
Castroagudin, J. F.
TRANSPLANTATION PROCEEDINGS, 2010, 42 (02) : 613 - 616
[32] The current status of immunotherapy and future horizon in the treatment of metastatic and locally advanced gastroesophageal adenocarcinoma
Nakayama, Izuma
Shitara, Kohei
EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (09) : 903 - 915
[33] The future of Liver Transplantation
Feng, Sandy
Roll, Garrett R.
Rouhani, Foad J.
Fueyo, Alberto Sanchez
HEPATOLOGY, 2024, 80 (03) : 674 - 697
[34] Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows
Costante, Federico
Airola, Carlo
Santopaolo, Francesco
Gasbarrini, Antonio
Pompili, Maurizio
Ponziani, Francesca Romana
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 14 (09) : 1622 - 1636
[35] Current State-of-the-Art Therapy for Malignant Pleural Mesothelioma and Future Options Centered on Immunotherapy
Cedres, Susana
Valdivia, Augusto
Iranzo, Patricia
Callejo, Ana
Pardo, Nuria
Navarro, Alejandro
Martinez-Marti, Alex
Assaf-Pastrana, Juan David
Felip, Enriqueta
Garrido, Pilar
CANCERS, 2023, 15 (24)
[36] Present status and future prospects in liver transplantation
Pirenne, J
Koshiba, T
INTERNATIONAL SURGERY, 1999, 84 (04) : 297 - 304
[37] Present and Future of Immunotherapy in Patients With Glioblastoma: Limitations and Opportunities
Maccari, Marta
Baek, Chooyoung
Caccese, Mario
Mandruzzato, Susanna
Fiorentino, Alba
Interno, Valeria
Bosio, Alberto
Cerretti, Giulia
Padovan, Marta
Idbaih, Ahmed
Lombardi, Giuseppe
ONCOLOGIST, 2024, 29 (04) : 289 - 302
[38] Current State and Future Possibilities in Liver Transplantation
Rademacher, Sebastian
Aehling, Niklas F.
Berg, Thomas
Sucher, Robert
Seehofer, Daniel
SURGICAL TECHNOLOGY INTERNATIONAL-INTERNATIONAL DEVELOPMENTS IN SURGERY AND SURGICAL RESEARCH, 2021, 39
[39] Acute liver failure and liver transplantation
Akamatsu, Nobuhisa
Sugawara, Yasuhiko
Kokudo, Norihiro
INTRACTABLE & RARE DISEASES RESEARCH, 2013, 2 (03) : 77 - 87
[40] Sarcopenia and failure to rescue following liver transplantation
Underwood, Patrick W.
Cron, David C.
Terjimanian, Michael N.
Wang, Stewart C.
Englesbe, Michael J.
Waits, Seth A.
CLINICAL TRANSPLANTATION, 2015, 29 (12) : 1076 - 1080

← 1 2 3 4 5 →